(Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H 3 receptors
- 1 May 2000
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 8 (5) , 1139-1149
- https://doi.org/10.1016/s0968-0896(00)00050-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Novel Partial Agonists for the Histamine H3 Receptor with High in Vitro and in Vivo ActivityJournal of Medicinal Chemistry, 1999
- Cloning and Functional Expression of the Human Histamine H3ReceptorMolecular Pharmacology, 1999
- Therapeutic potential of histamine H3 receptor agonists and antagonistsTrends in Pharmacological Sciences, 1998
- Imetit and N-methyl derivatives. The transition from potent agonist to antagonist at histamine H3 receptors.1Bioorganic & Medicinal Chemistry Letters, 1992
- Isothiourea analogues of histamine as potent agonists or antagonists of the histamine H3-receptorEuropean Journal of Medicinal Chemistry, 1992
- Two novel, potent and selective histamine H3 receptor agonistsBioorganic & Medicinal Chemistry Letters, 1992
- Autoinhibition of histamine synthesis mediated by presynaptic H3-receptorsNeuroscience, 1987
- Highly potent and selective ligands for histamine H3-receptorsNature, 1987
- Autoregulation of histamine release in brain by presynaptic H3-receptorsNeuroscience, 1985
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature, 1983